A neural circuits platform to accelerate and de-risk preclinical neuropsychiatric drug development
Time: 10:35 am
day: Day Two
Details:
• The need for improved in-vivo, in-brain pharmacodynamic readouts for
preclinical therapeutic development
• The Inscopix neural circuits platform for circuit-based
pharmacodynamics and efficacy assessments
• Case study: striatal circuit signatures corresponding to optimal
antipsychotic effect and clinical performance
Speakers:
Jonathan joined Inscopix in 2015. He received his PhD in Neuroscience from UCSD and did postdoctoral fellowships at Harvard Medical School and the Salk Institute. Jonathan is an experienced systems neurobiologist with research interests spanning neuroanatomy, in-vivo imaging, electrophysiology, optogenetics and behavioral measurements to study neural circuit function in rodents and non-human primates. At Inscopix,…Read more